ERBB2 and neoplasm: In disease biomarker detection, SPR aptasensors have been reported to detect and quantify cancer biomarkers like receptor tyrosine protein kinase (HER2), circulating tumor cells (CTC), and circulating tumor DNA (ctDNA), which have been established as reliable markers of progression in different cancer types [87].